ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CRL Charles River Laboratories International Inc

237.44
2.17 (0.92%)
Last Updated: 16:43:10
Delayed by 15 minutes
Share Name Share Symbol Market Type
Charles River Laboratories International Inc NYSE:CRL NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  2.17 0.92% 237.44 238.23 235.39 236.90 83,566 16:43:10

Charles River Laboratories to Present at Barclays Global Healthcare Conference

08/03/2021 1:30pm

Business Wire


Charles River Laboratories (NYSE:CRL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Charles River Laboratories Charts.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at the Barclays Global Healthcare Conference on Wednesday, March 10th, at 10:20 a.m. ET. Management will present an overview of Charles River’s strategic focus and business developments.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after the presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Investor Relations Contact: Todd Spencer Corporate Vice President, Investor Relations 781.222.6455 todd.spencer@crl.com

1 Year Charles River Laboratories Chart

1 Year Charles River Laboratories Chart

1 Month Charles River Laboratories Chart

1 Month Charles River Laboratories Chart

Your Recent History

Delayed Upgrade Clock